Compare EIKN & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EIKN | SGP |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.6M | 650.9M |
| IPO Year | N/A | N/A |
| Metric | EIKN | SGP |
|---|---|---|
| Price | $9.22 | $22.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $25.60 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 286.4K | 108.0K |
| Earning Date | 03-30-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.90 | $17.06 |
| 52 Week High | $16.50 | $30.56 |
| Indicator | EIKN | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 44.89 | 59.76 |
| Support Level | $8.43 | $20.95 |
| Resistance Level | $13.52 | $22.54 |
| Average True Range (ATR) | 0.73 | 1.35 |
| MACD | -0.08 | 0.24 |
| Stochastic Oscillator | 37.57 | 70.24 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.